Medico Remedies Limited

MEDICO

INE630Y01024

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:51 31/05/2024 BST			5-day change	1st Jan Change
36.9 ^INR	+0.16%		-1.73%	-55.86%

05-09	Medico Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
05-09	Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Medico Remedies Limited Announces the Resignation of Shweta Harshit Mehta as Wholetime Director

October 23, 2019 at 10:48 am

Medico Remedies Limited informed that Mrs. Shweta Harshit Mehta has resigned from the post of Wholetime Director effective 23 October, 2019.

Latest news about Medico Remedies Limited

Medico Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-09	CI
Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-09	CI
Medico Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Medico Remedies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Medico Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23	CI
Medico Remedies to Foray into Ointment Manufacturing Business	15/05/23	MT
Medico Remedies Limited Completes Trial Production Round At the Newly Established State of the Art Ointment Manufacturing Plant At Palghar	13/05/23	CI
Medico Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	11/05/23	CI
Medico Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	10/02/23	CI
Medico Remedies Gets Board Nod for Stock Split	02/02/23	MT
Medico Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12/08/22	CI
Medico Remedies Limited Announces Appointment of Deepesh Shah as an Additional Independent Director	22/04/22	CI
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2021	12/11/21	CI
Medico Remedies : Gets Board Nod for Bonus Share Issue	08/10/21	MT
Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2021	27/05/21	CI
834,900 Equity Shares of Medico Remedies Limited are subject to a Lock-Up Agreement Ending on 9-FEB-2021.	08/02/21	CI
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2020	12/11/20	CI
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2019	13/11/19	CI
Medico Remedies Limited Announces the Resignation of Shweta Harshit Mehta as Wholetime Director	23/10/19	CI
Medico Remedies Limited Announces Audited Financial Results for the Six Months and Year Ended March 31, 2019	25/05/19	CI
Medico Remedies Limited Appoints Dinesh Modi as Company Secretary	11/02/19	CI
2,215,100 Equity Shares of Medico Remedies Limited are subject to a Lock-Up Agreement Ending on 9-FEB-2019.	08/02/19	CI
Medico Remedies Pvt. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2018	14/11/18	CI
Medico Remedies Limited Announces Resignation of Vipul Premshankar Dubey as Company Secretary with Effect from September 30, 2018	24/09/18	CI
Medico Remedies Limited Reports Audited Earnings Results for the Six Months and Financial Year Ended March 31, 2018	25/05/18	CI

Medico Remedies Limited is an India-based pharmaceutical formulation manufacturing company. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. It has manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. In addition, the Company also manufactures other drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Paediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MEDICO REMEDIES LIMITED	-55.86%	36.69M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B